Julie M Yabu

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. pmc Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases
    J M Yabu
    Division of Nephrology, Department of Medicine, Stanford University, CA, USA
    Transplant Proc 45:82-7. 2013
  2. doi request reprint Kidney transplantation: the ideal immunosuppression regimen
    Julie M Yabu
    Department of Medicine, Division of Nephrology, Stanford University Medical Center, Palo Alto, CA 94304, USA
    Adv Chronic Kidney Dis 16:226-33. 2009
  3. doi request reprint C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation
    Julie M Yabu
    Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, CA 90095 7430, USA
    Transplantation 91:342-7. 2011
  4. ncbi request reprint Novel immunosuppression: small molecules and biologics
    Julie M Yabu
    Department of Medicine, University of California, San Francisco, Kidney Transplant Service, San Francisco, CA 94143, USA
    Semin Nephrol 27:479-86. 2007
  5. doi request reprint Posttransplantation anemia: mechanisms and management
    Julie M Yabu
    Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA
    Clin J Am Soc Nephrol 6:1794-801. 2011

Detail Information

Publications5

  1. pmc Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases
    J M Yabu
    Division of Nephrology, Department of Medicine, Stanford University, CA, USA
    Transplant Proc 45:82-7. 2013
    ..We conclude that early enrollment in paired kidney donor exchange and tailored desensitization protocols are key strategies to improve care and rates of kidney transplantation in highly sensitized patients...
  2. doi request reprint Kidney transplantation: the ideal immunosuppression regimen
    Julie M Yabu
    Department of Medicine, Division of Nephrology, Stanford University Medical Center, Palo Alto, CA 94304, USA
    Adv Chronic Kidney Dis 16:226-33. 2009
    ..Ultimately, the goal of prescribing immunosuppression is to transition from empiric therapy to one of individualized therapy...
  3. doi request reprint C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation
    Julie M Yabu
    Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, CA 90095 7430, USA
    Transplantation 91:342-7. 2011
    ..The aim of this study was to determine whether C1q-fixing antibodies distinguish de novo donor-specific antibodies (DSA) that are clinically relevant and harmful...
  4. ncbi request reprint Novel immunosuppression: small molecules and biologics
    Julie M Yabu
    Department of Medicine, University of California, San Francisco, Kidney Transplant Service, San Francisco, CA 94143, USA
    Semin Nephrol 27:479-86. 2007
    ..These new agents currently in preclinical and clinical trials appear promising and may represent the emergence of novel immunosuppressive agents that can deliver immunosuppression without long-term toxicity...
  5. doi request reprint Posttransplantation anemia: mechanisms and management
    Julie M Yabu
    Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA
    Clin J Am Soc Nephrol 6:1794-801. 2011
    ..This article reviews the prevalence, pathogenesis, and management of anemia in kidney transplant recipients...